CLINICAL TRIALS PROFILE FOR TRICAPRILIN
✉ Email this page to a colleague
Clinical Trials for Tricaprilin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00142805 ↗ | Tricaprilin in Mild to Moderate Alzheimer's Disease | Completed | Accera, Inc. | Phase 2 | The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease. |
NCT00142805 ↗ | Tricaprilin in Mild to Moderate Alzheimer's Disease | Completed | Cerecin | Phase 2 | The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease. |
NCT00355550 ↗ | Tricaprilin In Age-Associated Memory Impairment | Completed | Accera, Inc. | Phase 2 | The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life. |
NCT00355550 ↗ | Tricaprilin In Age-Associated Memory Impairment | Completed | Cerecin | Phase 2 | The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life. |
NCT03551769 ↗ | Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production | Completed | Accera, Inc. | Phase 1 | This is a Phase I, single center, open label, fixed-order, crossover, food-effect, pharmacokinetic (PK) study recruiting healthy, adult, male subjects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tricaprilin
Condition Name
Clinical Trial Locations for Tricaprilin
Trials by Country
Clinical Trial Progress for Tricaprilin
Clinical Trial Phase
Clinical Trial Sponsors for Tricaprilin
Sponsor Name